Rh2 or Its Aglycone APPD in Combination Therapy With Docetaxel-pre-clinical Evaluation in a PC-3 Human Prostate Xenograft Model
Dr Jeyran Shahbazi Supervisor: Dr Tao Liu Co-supervisor: Prof Richard Lock The BET Bromodomain inhibitor ( JQ1) and Histone Deacetylase inhibitor (Panobinostat)
